Fulgent Genetics, Inc.
Long

Oversold, potential to bounce

184
Sellers may have finally capitulated as this is oversold and turning up. Earnings could act as a catalyst for a run up.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.